About Pharmos
Pharmos was a Healthcare company based in Iselin (United States) founded in 1990 by Haim Aviv. Researches innovative medicines and vaccines to treat various diseases through online platforms. It operates on a B2C model in Healthcare and Consumer sectors. Pharmos has completed 1 acquisition, including Vela Pharmaceuticals. The company is recorded as dissolved. Pharmos offers products and services including Online Pharmacy and Medicines and Vaccines. Its focus areas include Pharmaceuticals, Medicines, Disease Remedies and Personal Hygiene Products. Its competitors include AbbVie, Lilly and Gilead.
Company details
Pharmos Corporation focuses on pharmaceutical research and innovation, developing remedies for a range of diseases including nasal congestion and other health issues. Scientists work daily to improve medicines and vaccines, operating an online pharmacy for product sales. Based in Iselin, New Jersey, USA, the company offers secure purchasing of healthcare products and supplements, emphasizing quality and accessibility for consumers worldwide.
- Headquarters Iselin, United States
- Founders Haim Aviv
- SectorsHealthcareConsumer
- Email••••••••
- Website pharmoscorp.com
- Social Facebook
- Latest Funding Round$1.8M (USD), Post-IPO
Apr 2009
- InvestorsVenrock
& 2 more
- Investments & Acquisitions
Products & Services of Pharmos
Pharmos offers a comprehensive portfolio of products and services, including Online Pharmacy and Medicines and Vaccines.
Platform for buying medicines and health products securely online
Innovative remedies for treating various diseases and conditions
Funding Insights of Pharmos
- Total Rounds 8
- Last Round Post-IPO — $1.8M
- First Round $5M
(Feb 1998)
- Investors Count 3
All 8 funding rounds of Pharmos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2009 | $1.8M | Post-IPO | – | – | |
| Jan 2008 | $4M | Post-IPO | – | – | |
| Mar 2007 | Grant | – | – | ||
| May 2005 | $1.3M | Grant | – | – | |
| Sep 2003 | $21M | Post-IPO | – | – | – |
| Jun 2003 | $8M | Post-IPO | – | – | – |
| Jun 2002 | Grant | – | – | ||
| Feb 1998 | $5M | Post-IPO | – | – | – |
3 investors in total: 3 institutional.
Investors in Pharmos
Pharmos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Venrock, NEA and National Insurance Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on tech sectors | venrock.com | Palo Alto, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Social security services are provided to Israeli residents. | btl.gov.il | Israel |
Investor details for Pharmos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pharmos
1 people are tracked at Pharmos (1 in leadership).
| Name | Role | Group |
|---|---|---|
Haim Aviv | Founder | Leadership |
Complete people profiles for Pharmos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmos
Pharmos has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vela Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapeutics for nervous system disorders were developed by Vela Pharmaceuticals. | velapharm.com | Lawrenceville, United States | 1998 | Mar 2006 | $29.7M |
Complete acquisition details for Pharmos
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Pharmos
4 dated milestones of Pharmos across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmos is founded.
- Funding First funding round of $5.0M.
- Acquisition Acquires Vela Pharmaceuticals.
- Funding Latest funding round, Post-IPO, of $1.8M.
Competitors of Pharmos
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abbvie.com | 2012 | Chicago, United States | 8,667 | Biopharmaceutical research and drug development are conducted globally by AbbVie. | ||
| lilly.com | 1876 | United States | 39,000 | Traditional pharmaceutical medicines are developed for multiple health fields. | ||
| gilead.com | 1987 | Foster, United States | 4,267 | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others |
Detailed competitors of Pharmos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Pharmos (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmos
Pharmos was founded in 1990 and raised its 1st funding round 8 years after it was founded.
Pharmos is headquartered in Iselin, United States. It is registered at Iselin, New Jersey, United States.
Pharmos Corporation focuses on pharmaceutical research and innovation, developing remedies for a range of diseases including nasal congestion and other health issues. Scientists work daily to improve medicines and vaccines, operating an online pharmacy for product sales. Based in Iselin, New Jersey, USA, the company offers secure purchasing of healthcare products and supplements, emphasizing quality and accessibility for consumers worldwide.
Pharmos offers Online Pharmacy and Medicines and Vaccines.
Pharmos has made 1 acquisition, including Vela Pharmaceuticals.
Pharmos has 3 investors. Key investors include Venrock, NEA, and National Insurance Institute.